BioGaia AB

BIOG B

SE0017769995

Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 01/07/2024 BST			5-day change	1st Jan Change
124.4 ^SEK	+0.57%		-1.66%	+22.92%

06-05	BioGaia AB Establishes Its Own Distribution in Australia and New Zealand	CI
05-07	Nordic Shares Closed Up Tuesday; Storskogen Group Series B Topped Leaders	DJ

BioGaia AB Approves Election of Robert Molander as Board Member

June 16, 2020 at 04:00 pm

BioGaia AB (publ) at its AGM held on June 16, 2020 approved the election of Robert Molander as board member.

Latest news about BioGaia AB

BioGaia AB Establishes Its Own Distribution in Australia and New Zealand	06-05	CI
Nordic Shares Closed Up Tuesday; Storskogen Group Series B Topped Leaders	05-07	DJ
Transcript : BioGaia AB, Q1 2024 Earnings Call, May 07, 2024	05-07
BioGaia AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Nordic Shares Rose Wednesday; BW LPG Led Increases	04-03	DJ
Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss	03-28	DJ
Nordic Stocks Moved Upward Wednesday; Nordic Semiconductor Climbed Highest	02-07	DJ
BioGaia AB to Seeks Acquisitions	02-07	CI
Transcript : BioGaia AB, Q4 2023 Earnings Call, Feb 07, 2024	02-07
BioGaia AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-07	CI
BioGaia AB Proposes an Extra Dividend, Payable on May 15, 2024	02-07	CI
Biogaia AB Proposes Ordinary Dividend, Payable on May 15, 2024	02-07	CI
Transcript : BioGaia AB, Q3 2023 Earnings Call, Oct 20, 2023	20/10/23
BioGaia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/10/23	CI
BioGaia AB Announces Nomination Committee for the 2024 Annual General Meeting	18/10/23	CI
Biogaia AB Provides Preliminarily Earnings Guidance for Third Quarter 2023	16/10/23	CI
Biogaia AB Appoints Theresa Agnew as CEO	25/09/23	CI
BioGaia AB Introduces BioGaia Prodentis KIDS in Sweden	01/09/23	CI
BioGaia Names New CEO	02/08/23	MT
BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023	02/08/23	CI
Transcript : BioGaia AB, Q2 2023 Earnings Call, Jul 21, 2023	21/07/23
BioGaia AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/07/23	CI
Nordic Shares Moved Upward Wednesday; Storskogen Group Series B Climbed Highest	12/07/23	DJ
BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults	05/07/23	CI
BioGaia AB Approves Election of Barbro Fridén, Outi Armstrong and Vesa Koskinen as Board Members	05/05/23	CI

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Companyâs activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licenseeâs dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.

Sector

Pharmaceuticals

Calendar

23/07/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for BioGaia AB

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

123.7 SEK

Average target price

150 SEK

Spread / Average Target

+21.26%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
BIOGAIA AB	+22.92%	1.18B
CSL LIMITED	+2.08%	95.18B
SAMSUNG BIOLOGICS CO.,LTD.	-0.13%	37.55B
BIOGEN INC.	-10.43%	33.75B
UCB	+77.76%	28.2B
BIOMARIN PHARMACEUTICAL INC.	-14.82%	15.63B
INCYTE CORPORATION	-3.06%	13.63B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.76%	11.5B
ALTEOGEN INC.	+181.73%	10.81B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-53.92%	9.23B

Biopharmaceuticals

BioGaia AB

Equities

BIOG B

SE0017769995

Pharmaceuticals

BioGaia AB Approves Election of Robert Molander as Board Member

Latest news about BioGaia AB

Chart BioGaia AB

Company Profile

Income Statement Evolution

Ratings for BioGaia AB

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Biopharmaceuticals